GeneReach Biotechnology Corp. (TPEX:4171)
12.20
-1.10 (-8.27%)
Nov 20, 2026, 1:21 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 693.67 million as of November 20, 2026. It is the 36,011th most valuable company in the world and the 2,137th biggest in Taiwan. Its market cap has decreased by 37.39% in one year.
Market Cap
693.67M
Enterprise Value
524.84M
Revenue
241.13M
Global Rank
Country Rank
#2,137 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 693.67M, a decrease of -45.49%. That is a compound annual growth rate of -4.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 693.67M | -36.06% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 967.26M |
| Level Biotechnology | 937.89M |
| BiOptic | 893.39M |
| TCI GENE | 873.13M |
| Holy Stone Healthcare | 861.25M |
| Lukas Biomedical | 824.93M |
| Meribank Biotech | 764.93M |
| NatureWise Biotech & Medicals | 690.51M |